Disparities in the use of colorectal cancer screening in a universally insured population during the COVID-19 pandemic.

We found a 21% reduction in the odds of CRC screening in the context of the COVID-19 pandemic. Reductions in colonoscopies and other types of screening tests were not offset by changes in the use of at-home tests such as Cologuard.